NRX Pharmaceuticals Inc. Warrant (NRXPW) Key Ratios
$0.01
$0.00 (0.00%)As on 28-May-2026 09:30EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 8.65 | 26,600.00 | 28,562.50 | -- | -- |
| EBIT | -216.10 | 78.28 | 73.97 | 22.49 | 7.86 |
| Net Profit | -497.22 | 74.06 | -1.79 | 10.33 | 7.67 |
| EPS | -489.97 | 86.83 | 39.07 | -165.40 | 14.15 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -2,281.71 | -2,281.71 | -264.11 | -2,281.71 | -- |
| Net Margin
| -- | -- | -1,070.26 | -- | -- |
| Return on equity
| 561.49 | 442.63 | -- | 146.18 | 143.76 |
| Return on Capital
| 16.04 | 141.06 | -- | 179.16 | 261.48 |
| Return on Assets
| -328.32 | -328.51 | -63.40 | -344.70 | -458.25 |
| Debt to Equity (x)
| -- | -- | 0.00 | -0.04 | -0.28 |
The underlying data is unavailable.